Medpace Holdings (MEDP) Other Operating Expenses (2015 - 2026)

Medpace Holdings has reported Other Operating Expenses for 12 years, with the latest figure at $510.4 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 34.16% year-over-year to $510.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (up 28.55% YoY), and the FY2025 full-year result was $1.8 billion, up 21.75% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $510.4 million, up from $503.3 million in the prior quarter.
• The five-year high for Other Operating Expenses was $510.4 million in Q1 2026, with the low at $233.1 million in Q1 2022.
• Historically, Other Operating Expenses has averaged $360.6 million across 5 years, with a median of $359.9 million in 2023.
• Annual changes were most pronounced in 2024 — Other Operating Expenses declined 0.97% — and 2025, when it jumped 40.35%.
• Medpace Holdings' Other Operating Expenses stood at $279.2 million in 2022, then rose by 29.71% to $362.1 million in 2023, then slipped by 0.97% to $358.6 million in 2024, then jumped by 40.35% to $503.3 million in 2025, then rose by 1.41% to $510.4 million in 2026.
• The last three Other Operating Expenses figures came in at $510.4 million (Q1 2026), $503.3 million (Q4 2025), and $463.2 million (Q3 2025), per Business Quant data.